We are monitoring the impact of COVID-19 on Autoimmune Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1125
Share on
Share on

Global Autoimmune Diagnostics Market Size, Share, Trends & Growth Analysis Report – Segmented By Test Type, Disease Type, End-User & Region - Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 1125
Pages: 182

Autoimmune Diagnostics Market Size (2020 to 2025)

The global autoimmune diagnostics market size was worth USD 14.03 billion in 2020 and is forecasted to worth USD 16.74 billion by the end of 2025. This market to register a CAGR of 3.6% between 2020 to 2025.

Autoimmune disease is a disorder where the patient’s immune system attacks its body tissues, leading to body organs' damage. Nearly 80 types of autoimmune diseases are known so far.

The global autoimmune diagnostics market is forecasted to have tremendous growth during the forecast period. It is receiving a significant boost from factors such as a rise in the prevalence of autoimmune disorders like people with type 1 diabetes in newborn babies with copulation of demand for rapid diagnostics. The high incidences of autoimmune diseases and growing awareness about autoimmune diseases are further contributing to the growth of the market.

Additionally, a rise in R & D on autoimmune diseases is predicted to favor the growth rate of the market. Across the globe, many research and diagnostics industries are undertaking new initiatives with a complication with government organizations by owning a rise in the prevalence of autoimmune disorders. They will have a consequence on healthcare expenditure, as per the National Institutes of Health (NIH) data published that these disorders are in the top ranking, which leads to an increment in mortality rates among women. The factors mentioned above are the primary and significant drivers of the autoimmune diagnostics market.   

Some of the restraints factors, such as the high frequency of false-positive results, and having an extended turnaround time for diagnostic test results, limit the market growth to a small extent. High expenditures, less awareness regarding various diseases, and diagnostic measures are other significant restraints. Moreover, fewer income companies and the rise of economy countries to address some issues for autoimmune diseases diagnostics market.

Impact of COVID-19 on the global autoimmune diagnostics market:

COVID-19 pandemic outbreak terrifically affected every market. After the WHO (World Health Organization) official announcement, it is observed that the COVID-19 pandemic changed the dynamic of the market, trends, and observed requirements. COVID-19 pandemic outbreak affected with the inclusion of current and future impact overall industry growth. Due to the rise in crisis, changes in requirements and trends are changing the economy's landscape. The primary wish of every market to get a vaccine for COVID-19 as soon as possible.   

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Test Type, Disease Type & Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli lilly and GlaxoSmithKline Plc.

 

This research report on the global autoimmune diagnostics market has been segmented and sub-segmented based on the test type, disease type, and region.

Autoimmune Diagnostics Market - By Test Type:

  • Autoantibody Tests
  • Antinuclear Antibody Tests
  • Complete Blood Count (CBC)
  • C-reactive protein (CRP) 
  • Comprehensive Metabolic panel  
  • Urinalysis 
  • Erythrocyte Sedimentation Rate (ESR)     
  • Others

Autoimmune Diagnostics Market - By Disease Type:

  • Localized autoimmune disease diagnostics
    • Graves' Disease
    • Hashimoto's Thyroiditis
    • Multiple Sclerosis
    • Type 1 diabetes
    • Psoriasis
    • Others
  • Systemic autoimmune disease diagnostics
    • Rheumatoid Arthritis (RA)
    • Ankylosing Spondylitis
    • Systemic Lupus Erythematosus (SLE)

Autoimmune Diagnostics Market - By End User:

  • Hospitals
  • Research Centers
  • Diagnostic Laboratories

Based on the end-user, the hospital segment contributes a significant share by recording a high compound annual growth rate in the global autoimmune diagnostics market. The hospital segment is owning many advantageous factors such as increment of patients' usage and the rise of chronic diseases cases.

Autoimmune Diagnostics Market - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the North American region is estimated to rule the global autoimmune diagnostics market during the forecast period with the highest share, followed by Europe, Asia Pacific. The Asia-pacific market is expected to account for the highest growth during the forecast period.

As anticipated, the North American region contributed to the highest revenue share above 39.2% in 2019. This North American region is owning factors such as the presence of favorable initiatives and regulations by AARDA. Moreover, the North American area is also having a high prevalence of diseases. 

During the forecast period, the Asia-Pacific region is having lucrative growth-share by owning many advantageous factors such as improving healthcare infrastructure and the rapid growth of patients’ awareness levels. Moreover, the Asia-Pacific region is having a rise in an increment of revenue share. The expected revenue share of the autoimmune diagnostics market in the Asia-Pacific region has a CAGR of over 22.0% from 19.5% in 2015 to 2025.

The European region is also accounting highest share due to presence of UK country during the forecast period. The European region is having advantageous factors such as increment of economic burden with copulation with increased research and developed activities further influencing the European region's growth. Additionally, the increment of demand for better and accurate diagnosis for systematic localized diseases positively impacts the autoimmune diagnostic market.

KEY MARKET PLAYERS:

Notable participants leading the global autoimmune diagnostics market profiled in the report are Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli Lilly and GlaxoSmithKline Plc.

MAJOR HAPPENINGS IN THIS MARKET IN THE RECENT PAST:

  • In 2019, ZEUS IFA test systems were launched by Cambridge Life Sciences limited in the US country.
  • In 2019, US FDA EUROIMMUN Anti-Tissue Transglutaminase ELISA approval was received by PerkinElmer, Inc. It will help the confirmation of clinicians for celiac disease diagnosis.
  • In 2019, an agreement was made between Exagen Inc. with GSK earlier extended for a year. This extension will help the key players to drive awareness about challenges by facing lupus diagnosis and management.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Test Type                              

                                5.1.1 Autoantibody Tests             

                                5.1.2 Antinuclear Antibody Tests              

                                5.1.3 Complete Blood Count (CBC)          

                                5.1.4 C - reactive protein (CRP) 

                                5.1.5 Comprehensive Metabolic panel   

                                5.1.6 Urinalysis 

                                5.1.7 Erythrocyte Sedimentation Rate (ESR)        

                                5.1.8 Others      

                5.2 By Disease Type                       

                                5.2.1 Localized auto immune disease diagnostics              

                                                5.2.1.1 Graves' Disease

                                                5.2.1.2 Hashimoto's Thyroiditis

                                                5.2.1.3 Multiple Sclerosis

                                                5.2.1.4 Type 1 diabetes

                                                5.2.1.5 Psoriasis

                                                5.2.1.6 Others

                                5.2.2 Systemic auto immune disease diagnostics

                                                5.2.2.1 Rheumatoid Arthritis (RA)

                                                5.2.2.2 Ankylosing Spondylitis

                                                5.2.2.3 Systemic Lupus Erythematosus (SLE)

                5.3 By End Users                             

                                5.3.1 Hospitals  

                                "5.3.2 Research centers

 

"             

                                5.3.3 Diagnostic laboratories      

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy           

                                6.2.6 France      

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan        

                                6.3.5 South Korea           

                6.4 Latin America                            

                                6.4.1 Introduction           

                                6.4.2 Brazil         

                                6.4.3 Mexico     

                                6.4.4 Rest of Latin America         

                6.5 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa        

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8. Market Leaders' Analysis                                        

                8.1 Bio-Rad                        

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Siemens Healthcare                

                8.3 Abbott Laboratories               

                8.4 Crescendo Bioscience                            

                8.5 Roche Diagnostics                    

                8.6 SQI Diagnostics                         

                8.7 AESKU Diagnostics                   

                8.8 INOVA Diagnostics                  

                8.9 BioMerieux SA                          

                8.10 Beckman Coulter Inc.                           

                8.11 Hemagen Diagnostics                          

                8.12 Quest Diagnostics                  

                8.13 Eli lilly                         

                8.14 Glaxosmithkline Plc                              

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Autoimmune diagnostics Market, By Region, From 2020 to 2025
  2. Global Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  3. Global Autoantibody Tests Market, By Region, From 2020 to 2025
  4. Global Antinuclear Antibody Tests Market, By Region, From 2020 to 2025
  5. Global Complete Blood Count (CBC) Market, By Region, From 2020 to 2025
  6. Global C - reactive protein (CRP) Market, By Region, From 2020 to 2025
  7. Global Comprehensive Metabolic panel Market, By Region, From 2020 to 2025
  8. Global Urinalysis Market, By Region, From 2020 to 2025
  9. Global Erythrocyte Sedimentation Rate (ESR) Market, By Region, From 2020 to 2025
  10. Global Other Test Types Market, By Region, From 2020 to 2025
  11. Global Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  12. Global Localized Autoimmune Diseases Diagnostics Market, By Region, From 2020 to 2025
  13. Global Systemic Autoimmune Diseases Diagnostics Market, By Region, From 2020 to 2025
  14. Global Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  15. Global Graves' Disease Market, By Region, From 2020 to 2025
  16. Global Hashimoto's Thyroiditis Market, By Region, From 2020 to 2025
  17. Global Multiple Sclerosis Market, By Region, From 2020 to 2025
  18. Global Type 1 diabetes Market, By Region, From 2020 to 2025
  19. Global Psoriasis Market, By Region, From 2020 to 2025
  20. Global Other Localized Autoimmune Diagnostics Market, By Region, From 2020 to 2025
  21. Global Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  22. Global Rheumatoid Arthritis (RA) Market, By Region, From 2020 to 2025
  23. Global Ankylosing Spondylitis Market, By Region, From 2020 to 2025
  24. Global Systemic Lupus Erythematosus (SLE) Market, By Region, From 2020 to 2025
  25. North America Autoimmune diagnostics Market, By Region, From 2020 to 2025
  26. North America Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  27. North America Autoantibody Tests Market, By Region, From 2020 to 2025
  28. North America Antinuclear Antibody Tests Market, By Region, From 2020 to 2025
  29. North America Complete Blood Count (CBC) Market, By Region, From 2020 to 2025
  30. North America C - reactive protein (CRP) Market, By Region, From 2020 to 2025
  31. North America Comprehensive Metabolic panel Market, By Region, From 2020 to 2025
  32. North America Urinalysis Market, By Region, From 2020 to 2025
  33. North America Erythrocyte Sedimentation Rate (ESR) Market, By Region, From 2020 to 2025
  34. North America Other Test Types Market, By Region, From 2020 to 2025
  35. North America Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  36. North America Localized Autoimmune Diseases Diagnostics Market, By Region, From 2020 to 2025
  37. North America Systemic Autoimmune Diseases Diagnostics Market, By Region, From 2020 to 2025
  38. United States Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  39. United States Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  40. Canada Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  41. Canada Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  42. North America Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  43. North America Graves' Disease Market, By Region, From 2020 to 2025
  44. North America Hashimoto's Thyroiditis Market, By Region, From 2020 to 2025
  45. North America Multiple Sclerosis Market, By Region, From 2020 to 2025
  46. North America Type 1 diabetes Market, By Region, From 2020 to 2025
  47. North America Psoriasis Market, By Region, From 2020 to 2025
  48. North America Other Localized Autoimmune Diagnostics Market, By Region, From 2020 to 2025
  49. United States Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  50. Canada Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  51. North America Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  52. North America Rheumatoid Arthritis (RA) Market, By Region, From 2020 to 2025
  53. North America Ankylosing Spondylitis Market, By Region, From 2020 to 2025
  54. North America Systemic Lupus Erythematosus (SLE) Market, By Region, From 2020 to 2025
  55. United States Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  56. Canada Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  57. Europe Autoimmune diagnostics Market, By Region, From 2020 to 2025
  58. Europe Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  59. Europe Autoantibody Tests Market, By Region, From 2020 to 2025
  60. Europe Antinuclear Antibody Tests Market, By Region, From 2020 to 2025
  61. Europe Complete Blood Count (CBC) Market, By Region, From 2020 to 2025
  62. Europe C - reactive protein (CRP) Market, By Region, From 2020 to 2025
  63. Europe Comprehensive Metabolic panel Market, By Region, From 2020 to 2025
  64. Europe Urinalysis Market, By Region, From 2020 to 2025
  65. Europe Erythrocyte Sedimentation Rate (ESR) Market, By Region, From 2020 to 2025
  66. Europe Other Test Types Market, By Region, From 2020 to 2025
  67. Europe Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  68. Europe Localized Autoimmune Diseases Diagnostics Market, By Region, From 2020 to 2025
  69. Europe Systemic Autoimmune Diseases Diagnostics Market, By Region, From 2020 to 2025
  70. U.K Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  71. U.K Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  72. Spain Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  73. Spain Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  74. Germany Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  75. Germany Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  76. Italy Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  77. Italy Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  78. France Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  79. France Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  80. Europe Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  81. Europe Graves' Disease Market, By Region, From 2020 to 2025
  82. Europe Hashimoto's Thyroiditis Market, By Region, From 2020 to 2025
  83. Europe Multiple Sclerosis Market, By Region, From 2020 to 2025
  84. Europe Type 1 diabetes Market, By Region, From 2020 to 2025
  85. Europe Psoriasis Market, By Region, From 2020 to 2025
  86. Europe Other Localized Autoimmune Diagnostics Market, By Region, From 2020 to 2025
  87. U.K Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  88. Spain Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  89. Germany Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  90. Italy Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  91. France Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  92. Europe Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  93. Europe Rheumatoid Arthritis (RA) Market, By Region, From 2020 to 2025
  94. Europe Ankylosing Spondylitis Market, By Region, From 2020 to 2025
  95. Europe Systemic Lupus Erythematosus (SLE) Market, By Region, From 2020 to 2025
  96. U.K Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  97. Spain Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  98. Germany Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  99. Italy Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  100. France Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  101. Asia-Pacific Autoimmune diagnostics Market, By Region, From 2020 to 2025
  102. Asia-Pacific Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  103. Asia-Pacific Autoantibody Tests Market, By Region, From 2020 to 2025
  104. Asia-Pacific Antinuclear Antibody Tests Market, By Region, From 2020 to 2025
  105. Asia-Pacific Complete Blood Count (CBC) Market, By Region, From 2020 to 2025
  106. Asia-Pacific C - reactive protein (CRP) Market, By Region, From 2020 to 2025
  107. Asia-Pacific Comprehensive Metabolic panel Market, By Region, From 2020 to 2025
  108. Asia-Pacific Urinalysis Market, By Region, From 2020 to 2025
  109. Asia-Pacific Erythrocyte Sedimentation Rate (ESR) Market, By Region, From 2020 to 2025
  110. Asia-Pacific Other Test Types Market, By Region, From 2020 to 2025
  111. Asia-Pacific Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  112. Asia-Pacific Localized Autoimmune Diseases Diagnostics Market, By Region, From 2020 to 2025
  113. Asia-Pacific Systemic Autoimmune Diseases Diagnostics Market, By Region, From 2020 to 2025
  114. China Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  115. China Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  116. India Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  117. India Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  118. Japan Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  119. Japan Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  120. South Korea Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  121. South Korea Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  122. Australia Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  123. Australia Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  124. Asia-Pacific Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  125. Asia-Pacific Graves' Disease Market, By Region, From 2020 to 2025
  126. Asia-Pacific Hashimoto's Thyroiditis Market, By Region, From 2020 to 2025
  127. Asia-Pacific Multiple Sclerosis Market, By Region, From 2020 to 2025
  128. Asia-Pacific Type 1 diabetes Market, By Region, From 2020 to 2025
  129. Asia-Pacific Psoriasis Market, By Region, From 2020 to 2025
  130. Asia-Pacific Other Localized Autoimmune Diagnostics Market, By Region, From 2020 to 2025
  131. China Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  132. India Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  133. Japan Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  134. South Korea Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  135. Australia Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  136. Asia-Pacific Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  137. Asia-Pacific Rheumatoid Arthritis (RA) Market, By Region, From 2020 to 2025
  138. Asia-Pacific Ankylosing Spondylitis Market, By Region, From 2020 to 2025
  139. Asia-Pacific Systemic Lupus Erythematosus (SLE) Market, By Region, From 2020 to 2025
  140. China Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  141. India Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  142. Japan Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  143. South Korea Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  144. Australia Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  145. Latin America Autoimmune diagnostics Market, By Region, From 2020 to 2025
  146. Latin America Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  147. Latin America Autoantibody Tests Market, By Region, From 2020 to 2025
  148. Latin America Antinuclear Antibody Tests Market, By Region, From 2020 to 2025
  149. Latin America Complete Blood Count (CBC) Market, By Region, From 2020 to 2025
  150. Latin America C - reactive protein (CRP) Market, By Region, From 2020 to 2025
  151. Latin America Comprehensive Metabolic panel Market, By Region, From 2020 to 2025
  152. Latin America Urinalysis Market, By Region, From 2020 to 2025
  153. Latin America Erythrocyte Sedimentation Rate (ESR) Market, By Region, From 2020 to 2025
  154. Latin America Other Test Types Market, By Region, From 2020 to 2025
  155. Latin America Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  156. Latin America Localized Autoimmune Diseases Diagnostics Market, By Region, From 2020 to 2025
  157. Latin America Systemic Autoimmune Diseases Diagnostics Market, By Region, From 2020 to 2025
  158. Brazil Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  159. Brazil Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  160. Argentina Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  161. Argentina Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  162. Mexico Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  163. Mexico Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  164. Latin America Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  165. Latin America Graves' Disease Market, By Region, From 2020 to 2025
  166. Latin America Hashimoto's Thyroiditis Market, By Region, From 2020 to 2025
  167. Latin America Multiple Sclerosis Market, By Region, From 2020 to 2025
  168. Latin America Type 1 diabetes Market, By Region, From 2020 to 2025
  169. Latin America Psoriasis Market, By Region, From 2020 to 2025
  170. Latin America Other Localized Autoimmune Diagnostics Market, By Region, From 2020 to 2025
  171. Brazil Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  172. Argentina Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  173. Mexico Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  174. Latin America Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  175. Latin America Rheumatoid Arthritis (RA) Market, By Region, From 2020 to 2025
  176. Latin America Ankylosing Spondylitis Market, By Region, From 2020 to 2025
  177. Latin America Systemic Lupus Erythematosus (SLE) Market, By Region, From 2020 to 2025
  178. Brazil Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  179. Argentina Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  180. Mexico Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  181. Middle East & Africa Autoimmune diagnostics Market, By Region, From 2020 to 2025
  182. Middle East & Africa Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  183. Middle East & Africa Autoantibody Tests Market, By Region, From 2020 to 2025
  184. Middle East & Africa Antinuclear Antibody Tests Market, By Region, From 2020 to 2025
  185. Middle East & Africa Complete Blood Count (CBC) Market, By Region, From 2020 to 2025
  186. Middle East & Africa C - reactive protein (CRP) Market, By Region, From 2020 to 2025
  187. Middle East & Africa Comprehensive Metabolic panel Market, By Region, From 2020 to 2025
  188. Middle East & Africa Urinalysis Market, By Region, From 2020 to 2025
  189. Middle East & Africa Erythrocyte Sedimentation Rate (ESR) Market, By Region, From 2020 to 2025
  190. Middle East & Africa Other Test Types Market, By Region, From 2020 to 2025
  191. Middle East & Africa Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  192. Middle East & Africa Localized Autoimmune Diseases Diagnostics Market, By Region, From 2020 to 2025
  193. Middle East & Africa Systemic Autoimmune Diseases Diagnostics Market, By Region, From 2020 to 2025
  194. Middle East Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  195. Middle East Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  196. Africa Autoimmune diagnostics Market, By Test Type, From 2020 to 2025
  197. Africa Autoimmune diagnostics Market, By Disease Type, From 2020 to 2025
  198. Middle East & Africa Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  199. Middle East & Africa Graves' Disease Market, By Region, From 2020 to 2025
  200. Middle East & Africa Hashimoto's Thyroiditis Market, By Region, From 2020 to 2025
  201. Middle East & Africa Multiple Sclerosis Market, By Region, From 2020 to 2025
  202. Middle East & Africa Type 1 diabetes Market, By Region, From 2020 to 2025
  203. Middle East & Africa Psoriasis Market, By Region, From 2020 to 2025
  204. Middle East & Africa Other Localized Autoimmune Diagnostics Market, By Region, From 2020 to 2025
  205. Middle East Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  206. Africa Localized Autoimmune Disease Diagnostics Market, By Type, From 2020 to 2025
  207. Middle East & Africa Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  208. Middle East & Africa Rheumatoid Arthritis (RA) Market, By Region, From 2020 to 2025
  209. Middle East & Africa Ankylosing Spondylitis Market, By Region, From 2020 to 2025
  210. Middle East & Africa Systemic Lupus Erythematosus (SLE) Market, By Region, From 2020 to 2025
  211. Middle East Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025
  212. Africa Systemic Auto-immune disease diagnostics Market, By Type, From 2020 to 2025

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample